Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Yoga programme for type-2 diabetes prevention (YOGA-DP) among high risk people in India: a multicentre feasibility randomised controlled trial protocol.
Chattopadhyay K, Mishra P, Singh K, Harris T, Hamer M, Greenfield SM, Lewis SA, Manjunath NK, Nair R, Mukherjee S, Harper DR, Tandon N, Kinra S, Prabhakaran D; YOGA-DP Study Team. Chattopadhyay K, et al. Among authors: mishra p. BMJ Open. 2020 Sep 6;10(9):e036277. doi: 10.1136/bmjopen-2019-036277. BMJ Open. 2020. PMID: 32895271 Free PMC article.
Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study.
Mishra P, Vamadevan AS, Roy A, Bhatia R, Naik N, Singh S, Amevinya GS, Ampah EA, Fernandez Y, Free C, Laar A, Prabhakaran D, Perel P, Legido-Quigley H. Mishra P, et al. Patient Prefer Adherence. 2021 Jun 23;15:1359-1371. doi: 10.2147/PPA.S285442. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 34188453 Free PMC article.
Yoga Program for Type 2 Diabetes Prevention (YOGA-DP) Among High-Risk People: Qualitative Study to Explore Reasons for Non-participation in a Feasibility Randomized Controlled Trial in India.
Mishra P, Greenfield SM, Harris T, Hamer M, Lewis SA, Singh K, Nair R, Mukherjee S, Krishnamurthy Manjunath N, Harper DR, Tandon N, Kinra S, Prabhakaran D, Chattopadhyay K. Mishra P, et al. Front Public Health. 2021 Sep 3;9:682203. doi: 10.3389/fpubh.2021.682203. eCollection 2021. Front Public Health. 2021. PMID: 34540780 Free PMC article. Clinical Trial.
Feasibility Trial of Yoga Programme for Type 2 Diabetes Prevention (YOGA-DP) among High-Risk People in India: A Qualitative Study to Explore Participants' Trial- and Intervention-Related Barriers and Facilitators.
Mishra P, Harris T, Greenfield SM, Hamer M, Lewis SA, Singh K, Nair R, Mukherjee S, Manjunath NK, Tandon N, Kinra S, Prabhakaran D, Chattopadhyay K. Mishra P, et al. Int J Environ Res Public Health. 2022 May 1;19(9):5514. doi: 10.3390/ijerph19095514. Int J Environ Res Public Health. 2022. PMID: 35564908 Free PMC article. Clinical Trial.
Yoga Programme for Type 2 Diabetes Prevention (YOGA-DP) Among High-Risk People in India: A Multicenter Feasibility Randomized Controlled Trial.
Chattopadhyay K, Mishra P, Singh K, Singh K, Harris T, Hamer M, Greenfield SM, Manjunath NK, Nair R, Mukherjee S, Tandon N, Lewis SA, Kinra S, Prabhakaran D; YOGA-DP Study Team. Chattopadhyay K, et al. Among authors: mishra p. Diabetes Ther. 2023 Jul;14(7):1137-1154. doi: 10.1007/s13300-023-01395-4. Epub 2023 Mar 31. Diabetes Ther. 2023. PMID: 37002475 Free PMC article.
Correction to: Yoga Programme for Type 2 Diabetes Prevention (YOGA-DP) Among High-Risk People in India: A Multicenter Feasibility Randomized Controlled Trial.
Chattopadhyay K, Mishra P, Singh K, Singh K, Harris T, Hamer M, Greenfield SM, Manjunath NK, Nair R, Mukherjee S, Tandon N, Lewis SA, Kinra S, Prabhakaran D; YOGA-DP Study Team. Chattopadhyay K, et al. Among authors: mishra p. Diabetes Ther. 2023 Jul;14(7):1155-1156. doi: 10.1007/s13300-023-01420-6. Diabetes Ther. 2023. PMID: 37223849 Free PMC article. No abstract available.
Yoga Programme for Type 2 Diabetes Prevention (YOGA-DP): A Qualitative Study Exploring the Trial Team's Facilitators and Challenges in Conducting a Feasibility Trial in India.
Mishra P, Greenfield SM, Harris T, Hamer M, Lewis SA, Singh K, Nair R, Mukherjee S, Tandon N, Kinra S, Manjunath NK, Prabhakaran D, Chattopadhyay K. Mishra P, et al. Diabetes Ther. 2023 Oct;14(10):1695-1709. doi: 10.1007/s13300-023-01450-0. Epub 2023 Aug 10. Diabetes Ther. 2023. PMID: 37561266 Free PMC article.
3,153 results